0001140361-17-013027.txt : 20170323 0001140361-17-013027.hdr.sgml : 20170323 20170323163630 ACCESSION NUMBER: 0001140361-17-013027 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170323 DATE AS OF CHANGE: 20170323 EFFECTIVENESS DATE: 20170323 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001600987 IRS NUMBER: 464137807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-245323 FILM NUMBER: 17710102 BUSINESS ADDRESS: STREET 1: 3525 DEL MAR HEIGHTS ROAD, #821 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (619) 987-7768 MAIL ADDRESS: STREET 1: 3525 DEL MAR HEIGHTS ROAD, #821 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: TOKALAS, INC. DATE OF NAME CHANGE: 20140225 D/A 1 primary_doc.xml X0707 D/A LIVE 0001600987 Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 858-434-1113 DELAWARE Tokalas, Inc. TOKALAS, INC. Corporation true 2013 Scott L. Glenn c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Director Cam L. Garner c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Director David F. Hale c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Director Lauren G. Otsuki c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Executive Officer Chief Operating Officer Langdon Miller c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Executive Officer Chief Medical Officer James B. Breitmeyer, M.D., Ph.D. c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Executive Officer Director President and Chief Executive Officer Brian Lannutti c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Executive Officer Chief Scientific Officer David Johnson c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Director Cam Gallagher c/o Oncternal Therapeutics, Inc. 3525 Del Mar Heights Rd., #821 San Diego CA CALIFORNIA 92130 Director Biotechnology Decline to Disclose 06b true 0001140361-16-089151 2015-07-27 true true true true false 0 23504838 17874045 5630793 false 111 0 0 0 false Oncternal Therapeutics, Inc. /S/ James B. Breitmeyer James B. Breitmeyer, M.D., Ph.D. President and Chief Executive Officer 2017-03-16